Patterns of hematopoietic lineage involvement in children with neurofibromatosis type 1 and malignant myeloid disorders

Blood

Volumn 88, Issue 11, 1996, Pages 4314-4320

  Miles, Darryl K ^b   Freedman, Melvin H ^b   Stephens, Karen ^b   Pallavicini, Maria ^b   Sievers, Eric L ^b   Weaver, Molly ^b   Grunberger, Tom ^b   Thompson, Patricia ^b   Shannon, Kevin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DNA;

ALLELE; ARTICLE; BURST FORMING UNIT E; CELL DIFFERENTIATION; CHILDHOOD LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; EPSTEIN BARR VIRUS; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; FEMALE; HUMAN; HUMAN CELL; INFANT; MALE; MYELOMONOCYTIC LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NEUROFIBROMATOSIS; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0029908346     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4314.bloodjournal88114314     Document Type: Article

References (54)

1. Riccardi VM, Eichner JE: Neurofibromatosis. Baltimore, MD, Johns Hopkins, 1986
2. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925, 1978
3. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Kan YW, Priest JR: Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood 79:1311, 1992
4. Gadner H, Haas OA: Experience in pediatric myelodysplastic syndromes. Hematol Clin North Am 6:655, 1992
5. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukemia/lymphoma: A population-based UKCCSG study. Br J Cancer 70:969, 1994
6. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O'Connell P, White R: A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193, 1990
7. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA, White R, O'Connell P: Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 62:187, 1990
8. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS: Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 249:181, 1990
9. Ballester R, Marchuk D, Boguski M, Saulino A, Letcher R, Wigler M, Collins F: The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 63:851, 1990
10. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, Clark R, O'Connell P, Cawthon RM, Innis MA, McCormick F: The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843, 1990
11. Xu G, Lin B, Tanaka K, Dunn D, Wood D, Gesteland R, White R, Weiss R, Tamanoi F: The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 63:835, 1990
12. Boguski M, McCormick F: Proteins regulating Ras and its relatives. Nature 366:643, 1993
13. Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49:4682, 1989
14. Hall A: The cellular functions of small GTP-binding proteins. Science 249:635, 1990
15. Satoh T, Nakafuku M, Miyajima A, Kaziro Y: Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci USA 88:3314, 1991
16. Rodenhuis S: ras and human tumors. Semin Cancer Biol 3:241, 1992
17. Pierce JH, Aaronson SA: Myeloid cell transformation by ras-containing murine sarcoma viruses. Mol Cell Biol 5:667, 1985
18. Kahn P, Frykberg L, Brady C, Stanley I, Beug H, Vennstrom B, Graf T: v-erbA cooperates with sarcoma oncogenes in leukemic cell transformation. Cell 45:349, 1986
19. Lubbert M, Mirro J, Kitchingman G, McCormick F, Mertelesmann R, Herrmann F, Koeffler P: Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 7:263, 1992
20. Neubauer A, Shannon KM, Liu E: Mutations of the ras protooncogenes in childhood monosomy 7. Blood 77:594, 1991
21. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S: Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248, 1994
22. ras. Blood 84:3435, 1994
23. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
24. Bollag G, Clapp DW, Shih S, Adler F, Zhang Y, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat Genet 12:144, 1996
25. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte-macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 12:137, 1996
26. Freedman MH, Estrov Z, Chan HSL: Juvenile chronic myelogenous leukemia. Am J Pediatr Hematol Oncol 10:261, 1988
27. Xu G, Nelson L, O'Connell P, White R: An Alu polymorphism intragenic to the neurofibromatosis, type 1 gene. Nucleic Acids Res 19:3764, 1991
28. Andersen LB, Tarle SA, Marchuk DA, Legius E, Collins FS: A highly informative compound nucleotide repeat in the neurofibromatosis (NF1) gene. Hum Mol Genet 2:1083, 1993
29. Lazaro C, Gaona A, Estivill X: Two CA/GT repeat polymorphisms in intron 27 of the human NF1 gene. Hum Genet 93:351, 1994
30. Jensen S, Paderanga D, Chen P, Olson K, Edwards M, Iavorone A, Israel M, Shannon K: Molecular analysis at the NF1 locus in astrocytic brain tumors. Cancer 76:674, 1995
31. Neitzel H: A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum Genet 73:320, 1986
32. Weinberg RA: Tumor suppressor genes. Science 254:1138, 1991
33. Knudson AG: All in the (cancer) family. Nat Genet 5:103, 1993
34. Jacks T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nat Genet 7:353, 1994
35. Amenomori T, Tomonaga M, Yoshida Y, Kuriyama K, Matsuo T, Jinnai I, Ichimaru M, Omiya A, Tsuji Y: Cytogenic evidence for partially committed myeloid progenitor cell origin of chronic myelomonocytic leukaemia and juvernile chronic myeloid leukaemia: Both granulocyte-macrophage precursors and erythroid precursors carry identical marker chromosome. Br J Haematol 64:539, 1986
36. Busque L, Gilliland DG, Prchal JT, Sieff CA, Weinstein HA, Sokol JM, Belcikova M, Wayne AS, Zuckerman KS, Sokal L, Castleberry RP, Emanuel PD: Clonality in juvenile chronic myelogenous leukemia. Blood 85:21, 1995
37. Fialkow PJ, Denman AM, Jacobson RJ, Lowenthal MN: Chronic myelocytic leukemia: Origin of some lymphocytes from leukemic stem cells. J Clin Invest 62:815, 1978
38. Bernheim A, Berger R, Prud'Homme JL, Labaume S, Bussel A, Barot-Ciorbaru R: Philadelphia chromosome positive blood B lymphocytes in chronic myeloid leukemia. Leuk Ras 5:331, 1981
39. Lawrence HJ, Broudy VC, Magenis RE, Olson S, Tomar D, Barton S, Fitchen JH, Bagby GC: Cytogenetic evidence for involvement of B lymphocytes in acquired sideroblastic anemia. Blood 70:1003, 1987
40. White NJ, Nacheva E, Asimakopoulos FA, Bloxham D, Paul B, Green AR: Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood 83:2809, 1994
41. Kere J, Ruutu U, Lahtinen R, de la Chapelle A: Monosomy 7 in granulocytes and monocytes in myelodysplastic syndrome. N Engl J Med 316:499, 1987
42. Kroef MJPL, Fibbe WE, Mout R, Janssen RPM, Haak HL, Wessels JW, Van Kamp H, Willemze R, Landegent JE: Myeloid but not lymphoid cells carry the 5q deletiuon: Polymerase chain reaction analysis of loss of heterozygosity using mini-repeat sequences on highly purified cell fractions. Blood 81:1849, 1993
43. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Seletive hypersensitivity to granulocyte-macrophage colony stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925, 1991
44. Freedman MH, Cohen A, Grunberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z: Central role of tumor necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukemia. Br J Haematol 80:40, 1992
45. Papayannopoulou T, Nakamoto B, Anagnou NP, Chui D, Dow L, Sanders J: Expression of embryonic globins by erythroid cells in juvenile chronic myelocytic leukemia. Blood 77:2569, 1991
46. Privitera E, Schiro' R, Longoni D, Ronchi A, Rambaldi A, Bernasconi S, Ottolenghi S, Masera G, Biondi A: Constitutive expression of GATA-1, EPOR, α-globin, and γ-globin genes in myeloid clonogenic cells from juvenile chronic myelocytic leukemia. Blood 86:323, 1995
47. Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Zonghan D, Nanxin L, Batzer A, Rabun KM, Der CJ, Schlessinger D, Gishizky ML: BCR-ABL-Induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 75:175, 1993
48. Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD: Tyrosine phosphorylation of RasGAP and associated proteins in chronic myelogenous leukemia cell lines. Blood 79:2215, 1992
49. Raitano AB, Halpern JR, Hambuch TM, Sawyers CL: The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci USA 92:11746, 1995
50. Sawyers CL, McLaughlin J, Witte ON: Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene. J Exp Med 18:307, 1995
51. Kaneko Y, Maseki N, Sakuri M, Shibuya A, Shinohara T, Fujimoto T, Kanno H, Nishikawa A: Chromosome patterns in juvenile chronic myelogenous leukemia, myelodysplastic syndrome, and acute leukemia associated with neurofibromatosis. Leukemia 3:36, 1989
52. Luna-Fineman S, Shannon K, Lange BJ: Childhood monosomy 7: Epidemiology, biology and mechanistic implications. Blood 85:1985, 1995
53. Hall JG: Genomic imprinting: Review and relevance to human diseases. Am J Hum Genet 46:857, 1990
54. Sapienza C: Genome imprinting, cellular mosaicism and carcinogenesis. Mol Carcinog 3:118, 1990